Item 2.02 Result of Operations and Financial Condition.

On February 20, 2020, NuVasive, Inc. (the "Company") issued a press release announcing its financial results for the quarter and full year ended December 31, 2019. A copy of this press release is furnished as Exhibit 99.1 to this Current Report.

Item 7.01 Regulation FD Disclosure.

During a conference call scheduled to be held at 1:30 p.m. Pacific Time on February 20, 2020, the Company's Chief Executive Officer and Chief Financial Officer will discuss the Company's results for the quarter and full year ended December 31, 2019 and the Company's outlook for the year ending December 31, 2020.

The information contained in this Current Report and the Exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.




Item 9.01   Financial Statements and Exhibits.

(d)         Exhibits.

Exhibit No. Description 99.1 Press Release issued by NuVasive, Inc. on February 20, 2020 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses